Enzo Biochem, Inc. Announces Issuance of United States Patent for Advanced Nucleic Acid Hybridization Probe Technology for Clinical and Research Applications

Transformative Development in Diagnostic Testing, Drug Development and Academic Research Marketplace Provides a Simple, Cost Effective and Scalable Process — — New Probe Technology Advances Company’s Ability to Offer Lower-Cost High-Performance Products and Services in the Clinical Diagnostics Market NEW YORK, NY, August 5, 2019 — Enzo Biochem, Inc. (NYSE: ENZ), an integrated diagnostics and... Read more

Enzo Biochem to Acquire New Facility for Manufacturing and Distribution to Advance Its Diagnostic and Therapeutic Growth Strategy

Facility Will Enhance Enzo’s Ability to Produce and Distribute Its Growing Portfolio of Molecular Assays, Immunohistochemistry, Immunoassays and Immuno-oncology Products and Services Anticipates Significant Tax and Other Incentives for Enzo’s Entire Farmingdale New York Campus August 27, 2018 05:30 AM Pacific Daylight Time NEW YORK–(BUSINESS WIRE)–Enzo Biochem, Inc. (NYSE:ENZ), an integrated diagnostic and therapeutics company,... Read more

ENZO BIOCHEM REPORTS DELAWARE COURT RULING

NEW YORK, NY, June 29, 2017 – Enzo Biochem Inc. (NYSE: ENZ) reported today that a federal judge for the U.S. District Court for the District of Delaware has entered an order in the actions entitled Enzo Life Sciences, Inc. v. Gen-Probe Incorporated, Enzo Life Sciences, Inc. v. Hologic, Inc., Enzo Life Sciences, Inc. v. Roche Molecular... Read more

Enzo Life Sciences Introduces Innovative Ultra-Sensitive Multiplex IHC Kit

Enzo Life Sciences is pleased to unveil our newest immunohistochemistry product, MULTIVIEW® PLUS (mouse-HRP/rabbit-AP) IHC Kit (Brown/Green). This non-biotin nanopolymer detection system contains reagents and materials that detect and localize antigens in formalin-fixed paraffin-embedded tissues. The new MULTIVIEW PLUS IHC kit optimizes your IHC process by including the entire workflow, from antigen retrieval to visualization.... Read more

Enzo Life Sciences Launches New Compound Library to Provide Essential Standards for Cancer Inhibitor Screening

Enzo Life Sciences is proud to introduce the SCREEN-WELL® Cancer Library, a collection of 275 ready-to-use compounds for use in cancer inhibitor screening and assay development. The SCREEN-WELL® Cancer Library is comprised of compounds that are dissolved at 10 mM in DMSO and aliquoted at 100 µL per well in deep 96-well plates. It contains... Read more